These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25834576)

  • 1. Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resonance imaging: a feasibility study.
    Buch K; Morancy T; Kaplan I; Qureshi MM; Hirsch AE; Rofksy NM; Holupka E; Oismueller R; Hawliczek R; Helbich TH; Bloch BN
    J Contemp Brachytherapy; 2015 Jan; 6(4):337-43. PubMed ID: 25834576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy.
    Wright JL; Newhouse JH; Laguna JL; Vecchio D; Ennis RD
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):426-35. PubMed ID: 15145159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
    Crook J; McLean M; Yeung I; Williams T; Lockwood G
    Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience.
    Bloch BN; Lenkinski RE; Helbich TH; Ngo L; Oismueller R; Jaromi S; Kubin K; Hawliczek R; Kaplan ID; Rofsky NM
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):70-8. PubMed ID: 17513062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
    Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
    Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
    Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
    J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
    Teunissen FR; Wortel RC; Wessels FJ; Claes A; van de Pol SMG; Rasing MJA; Meijer RP; van Melick HHE; de Boer JCJ; Verkooijen HM; van der Voort van Zyp JRN
    Clin Transl Radiat Oncol; 2022 Jan; 32():29-34. PubMed ID: 34825071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
    McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
    Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
    Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
    Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy.
    Kiteley RA; Lee WR; deGuzman AF; Mirzaei M; McCullough DL
    Brachytherapy; 2002; 1(2):90-4. PubMed ID: 15062176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating Routine Magnetic Resonance Imaging-based Planning for the Delivery of High-dose-rate Brachytherapy for Prostate Cancer: An Evaluation of Clinical Feasibility and Dosimetric Outcomes.
    Saigal K; All S; Potrebko P; Feranec N; Keller A; Lizaso M; Warner C; Nguyen N; Jain A; Biagioli M
    Cureus; 2019 Feb; 11(2):e4085. PubMed ID: 31019863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.
    Martin GV; Pugh TJ; Mahmood U; Kudchadker RJ; Wang J; Bruno TL; Bathala T; Blanchard P; Frank SJ
    Brachytherapy; 2017; 16(4):761-769. PubMed ID: 28501429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
    Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of intraoperative magnetic resonance imaging/ultrasound fusion optimization for low-dose-rate prostate brachytherapy.
    Abel S; Renz P; Gayou O; Tang J; Werts ED; Trombetta M
    J Contemp Brachytherapy; 2017 Aug; 9(4):309-315. PubMed ID: 28951749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy.
    Lee J; Hobbs RF; Zahurak M; Ng SK; Zhang Z; Burdette EC; DeWeese TL; Song DY
    Brachytherapy; 2018; 17(6):858-865. PubMed ID: 30217432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.
    Potters L; Cao Y; Calugaru E; Torre T; Fearn P; Wang XH
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):605-14. PubMed ID: 11395226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases.
    Fuller DB; Jin H; Koziol JA; Feng AC
    Brachytherapy; 2005; 4(3):207-16. PubMed ID: 16182221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study.
    Cassidy RJ; Yang X; Liu T; Thomas M; Nour SG; Jani AB
    Med Dosim; 2016 Winter; 41(4):339-343. PubMed ID: 27745996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy radiation doses to the neurovascular bundles.
    DiBiase SJ; Wallner K; Tralins K; Sutlief S
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1301-7. PubMed ID: 10725644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.